Comparative work starts with named reagents
Literature on incretin and glucagon-family receptors often compares single agonists with dual or triple constructs. For a laboratory, the operational problem is labeling: catalog nicknames, internal codes, and published identifiers can drift apart. Before a head-to-head assay, confirm that each vial’s COA matches the structure you think you are using.
Receptor selectivity claims in papers describe experimental systems. They are not specifications you can paste onto a research catalog page as a use instruction. Treat each analog as its own chemical lot with its own identity data.
Study-design reminders
- Do not pool analogs from different lots into one “GLP” stock
- Report vendor, catalog name, and lot in the methods section
- Keep RUO materials inside institutional research policy
Biofusion Wellness lists research peptides for qualified programs and keeps batch records so comparative studies can cite what was actually on the bench.
Contact Information
Email: info@biofusionwellness.com